Filing Flows

Filing Flows › Sight Sciences (SGHT) › Next earnings date

Sight Sciences (SGHT) earnings: missed the estimate

Sight Sciences (SGHT) reported on Nov 4, 2026 and missed the EPS estimate: −$0.12 against −$0.12 (-0.5%). Revenue was $24.9M for Q3 2026, +25% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result−0.5% vs estimate
Beat rate60%

The last report

Sight Sciences reported revenue of $24.9M for the third quarter 2026 (+25% Y/Y), net loss $6.8M: Surgical Glaucoma $21.0M, Dry Eye $3.9M. How it makes money → · Every quarter →

Sight Sciences: EPS against the estimate, last 5 reportsSight Sciences: EPS against the estimate, last 5 reportsEstimateReported−$0.26−$0.16Nov 25−$0.14−$0.08Mar 26−$0.20−$0.24May 26−$0.14−$0.08Aug 26−$0.12−$0.12Nov 26
Latest (Nov 26): Estimate −$0.12, Reported −$0.12.

Sight Sciences' latest quarter

Sight Sciences, Q3 2026: revenue $24.9M (+25% year over year), operating margin -24.6%, net loss $6.8M, operating cash flow −$2.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Sight Sciences beat earnings?

Sight Sciences (SGHT) reported on Nov 4, 2026 and missed the EPS estimate: −$0.12 against −$0.12 (-0.5%).

When does SGHT report earnings?

The next date is not set yet.

Does Sight Sciences usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.